A Retrospective Study of COVID-19 Treatments
Completed
- Conditions
- Covid19COVID-19 Respiratory InfectionCOVID-19 Lower Respiratory InfectionCOVID-19 Acute BronchitisCOVID-19 PneumoniaSARS-CoV2 InfectionSARS-CoV-2 Acute Respiratory DiseaseCOVID-19 Acute Respiratory Distress Syndrome
- Interventions
- Other: No Intervention Used
- Registration Number
- NCT04949230
- Lead Sponsor
- ProgenaBiome
- Brief Summary
Surveys administered to subjects who have recovered from COVID-19 to assess how effective their treatment was.
- Detailed Description
Subjects who have recovered from COVID-19 will answer questions regarding the severity of their illness, symptoms experienced, what treatment they received, and how long they were ill.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
- Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
- Male or female of 18 years of age or older
- Diagnosis of COVID-19 infection by RT- PCR
- Recovery from COVID-19
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description COVID-19 Patients No Intervention Used Subjects who have recovered from COVID-19
- Primary Outcome Measures
Name Time Method Survey Response One hour Answers given by subjects on their recovery from COVID-19
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Ginger Aurella
🇺🇸Ventura, California, United States